References
Garduño-Sánchez S, Villanego-Beltrán I, de las Peñas-Cabrera MD, et al. Comparison between accelerated partial breast irradiation with multicatheter interstitial brachytherapy and whole breast irradiation, in clinical practice. Clin Transl Oncol. 2021. https://doi.org/10.1007/s12094-021-02664-z (Published Online First: 2 July).
Schäfer R, Strnad V, Polgár C, et al. Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. Lancet Oncol. 2018;19:834–44. https://doi.org/10.1016/S1470-2045(18)30195-5.
The Breast International Group. NSABP B-39, RTOG 0413: a randomized phase III Study of conventional whole breast irradiation versus partial breast irradiation for women with stage 0, I, or II breast cancer. Clin Adv Hematol Oncol. 2006;4:719–21.
Polgár C, Major T, Takácsi-Nagy Z, et al. Breast-conserving surgery followed by partial or whole breast irradiation: twenty-year results of a phase 3 clinical study. Int J Radiat Oncol Biol Phys. 2021;109:998–1006. https://doi.org/10.1016/j.ijrobp.2020.11.006.
Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987–1001. https://doi.org/10.1016/j.ijrobp.2009.02.031.
Polgár C, Van Limbergen E, Pötter R, et al. Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). Radiother Oncol. 2010;94:264–73. https://doi.org/10.1016/j.radonc.2010.01.014.
Valachis A, Mauri D, Polyzos NP, et al. Partial breast irradiation or whole breast radiotherapy for early breast cancer: a meta-analysis of randomized controlled trials. Breast J. 2010;16:245–51. https://doi.org/10.1111/j.1524-4741.2010.00905.x.
Marta GN, Macedo CR, de Andrade Carvalho H, et al. Accelerated partial irradiation for breast cancer: systematic review and meta-analysis of 8653 women in eight randomized trials. Radiother Oncol. 2015;114:42–9. https://doi.org/10.1016/j.radonc.2014.11.014.
Hickey BE, Lehman M, Francis DP, et al. Partial breast irradiation for early breast cancer. Cochrane Database Syst Rev. 2016;7:CD007077. https://doi.org/10.1002/14651858.CD007077.pub3.
Ye X-P, Bao S, Guo L-Y, et al. Accelerated partial breast irradiation for breast cancer: a meta-analysis. Transl Oncol. 2013;6:619–27.
Vaidya JS, Bulsara M, Wenz F, et al. Reduced mortality with partial-breast irradiation for early breast cancer: a meta-analysis of randomized trials. Int J Radiat Oncol Biol Phys. 2016;96:259–65. https://doi.org/10.1016/j.ijrobp.2016.05.008.
Meattini I, Marrazzo L, Saieva C, et al. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial. JCO. 2020;38:4175–83. https://doi.org/10.1200/JCO.20.00650.
Taylor CW, Wang Z, Macaulay E, et al. Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003–2013. Int J Radiat Oncol Biol Phys. 2015;93:845–53. https://doi.org/10.1016/j.ijrobp.2015.07.2292.
Khan AJ, Chen PY, Yashar C, et al. Three-fraction accelerated partial breast irradiation (APBI) delivered with brachytherapy applicators is feasible and safe: first results from the TRIUMPH-T trial. Int J Radiat Oncol Biol Phys. 2019;104:67–74. https://doi.org/10.1016/j.ijrobp.2018.12.050.
Kinj R, Chand M-E, Gal J, et al. Five-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly. Radiat Oncol. 2019;14:234. https://doi.org/10.1186/s13014-019-1448-0.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Not applicable.
Ethical approval
Not applicable.
Informed consent
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Garduño-Sánchez, S., Villanego-Beltrán, I., de las Peñas-Cabrera, M.D. et al. Response to letter to the Editor. Clin Transl Oncol 24, 1831–1832 (2022). https://doi.org/10.1007/s12094-022-02828-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-022-02828-5